In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Indian drugmaker Glenmark Pharmaceuticals has announced that Alessandro Riva will join its new innovation company as chief executive. The appointment is effective April 2, 2019. 7 March 2019
Biotechnology
Dutch biopharma Kiadis Pharma today announced senior management appointments to further strengthen the company as it transitions into commercial stage. 6 March 2019
Pharmaceutical
USA-based Corbus Pharmaceutical has announced the appointment of Craig Millian to the company as its first chief commercial officer ahead of the potential US Food and Drug Administration approval and commercial launch of its lead drug candidate lenabasum in 2021. 5 March 2019
Pharmaceutical
US-based Sunovion Pharmaceuticals, a subsidiary of Japan’s Sumitomo Dainippon Pharma, has appointed Antony Loebel as president and chief executive. 5 March 2019
Biotechnology
UK-based biotech firm Emergex Vaccines today announces the appointment of Athanasios Papadopoulos as chief medical officer, effective March 1, 2019. 27 February 2019
Biosimilars
A woman who has been involved in biosimilars since work on their development first began two decades ago, has been named director general of the International Generic and Biosimilar medicines Association (IGBA). 21 February 2019
Biotechnology
The UK’s BioIndustry Association (BIA) chairwoman Dr Jane Osbourn has announced this week that she is to leave AstraZeneca after 25 years with Cambridge Antibody Technology and MedImmune, where she is vice president R&D and site leader, the trade group announced yesterday. 19 February 2019
Biotechnology
UK-based Emergex Vaccines has secured a research and development (R&D) facility and hired a chief scientific officer (CSO). 18 February 2019
Pharmaceutical
Mundipharma has appointed Patrice Grand as European director of corporate communications, reporting to Alberto Martinez, president and chief executive in Europe. 18 February 2019
Pharmaceutical
Spanish family-owned drugmaker Esteve has appointed Jordi Muntañola as the new chief commercial officer for Europe, taking on the leadership of all the pharmaceutical activities in Spain and Europe. 15 February 2019
Pharmaceutical
Privately-held French drugmaker Pierre Fabre Group has appointed Maarten Kraan to the position of director of research and development for Pierre Fabre Pharmaceuticals (PFM), reporting to Frédéric Duchesne, chief executive of the Pharmaceuticals Division, and will sit on the branch’s executive committee. 8 February 2019
Pharmaceutical
Appaloosa, the US hedge fund managed by billionaire David Tepper, has called for major and immediate change at Allergan, the Ireland-based drugmaker that is best known for its Botox (onabotulinumtoxinA) product. 6 February 2019
Biotechnology
Dutch biopharma Kiadis Pharma has announced the appointment of Robert Friesen as chief scientific officer (CSO) effective February 1, 2019. 5 February 2019
Biotechnology
Swiss pharma giant Roche’s Genentech subsidiary has appointed Alexander Hardy as chief executive, effective March 1, 2019. 25 January 2019
Biotechnology
Sangamo Therapeutics has appointed Adrian Woolfson as executive vice president of R&D, effective January 22, 2019. 23 January 2019
Pharmaceutical
The man leading the UK and Ireland operations in what Takeda calls the company’s ‘new phase’ will be Jon Neal, it has been confirmed. 22 January 2019
Pharmaceutical
Danish CNS specialist Lundbeck today announced that it has appointed Dr Johan Luthman as executive vice president and head of R&D. 22 January 2019
Pharmaceutical
Sir Philip Hampton, who since 2015 has been the non-executive chairman of GlaxoSmithKline, will step down from the role with the UK drugmaker. 21 January 2019
Biotechnology
UK-based T cell receptor (TCR) biotech firm Immunocore today named David Berman as its new head of research and development. 16 January 2019
Generics
Perrigo today announced that James Dillard has been appointed executive vice president and chief scientific officer. 14 January 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze